Microba Life Sciences Limited (ASX: MAP)
Australia flag Australia · Delayed Price · Currency is AUD
0.195
+0.010 (5.41%)
Dec 27, 2024, 3:28 PM AEST

Microba Life Sciences Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2019
Market Capitalization
877210355--
Upgrade
Market Cap Growth
-30.59%-30.59%88.15%---
Upgrade
Enterprise Value
68456246--
Upgrade
Last Close Price
0.200.160.280.19--
Upgrade
PS Ratio
6.615.9319.0511.70--
Upgrade
PB Ratio
2.121.742.681.64--
Upgrade
P/TBV Ratio
3.013.012.691.65--
Upgrade
EV/Sales Ratio
5.613.7211.539.77--
Upgrade
Debt / Equity Ratio
0.040.040.030.040.020.07
Upgrade
Asset Turnover
0.230.230.130.160.250.23
Upgrade
Inventory Turnover
4.284.285.465.323.975.81
Upgrade
Quick Ratio
2.362.365.056.504.382.64
Upgrade
Current Ratio
2.612.615.316.804.842.85
Upgrade
Return on Equity (ROE)
-49.98%-49.98%-35.17%-47.33%-66.46%-65.65%
Upgrade
Return on Assets (ROA)
-30.76%-30.76%-29.26%-35.09%-40.63%-37.66%
Upgrade
Return on Capital (ROIC)
-39.14%-39.14%-33.91%-40.63%-50.70%-43.98%
Upgrade
Earnings Yield
-24.95%-27.83%-12.28%-20.90%--
Upgrade
FCF Yield
-19.53%-23.80%-12.54%-22.02%--
Upgrade
Buyback Yield / Dilution
-30.42%-30.42%-40.87%-21.61%-17.01%-
Upgrade
Total Shareholder Return
-30.42%-30.42%-40.87%-21.61%-17.01%-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.